"No benefit to dual RAS blockade in meta-analysis"
Heart Jan 29
http://www.theheart.org/article/1500459.do
"A large meta-analysis of randomized trials comparing dual blockade of the renin-angiotensin system (RAS) with ACE inhibitors and angiotensin-receptor blockers (ARBs) failed to show any benefit in terms of reducing mortality compared with monotherapy "